Retatrutide Reaches Major Phase 3 Milestone: Could Lilly’s Triple Agonist Become the Most Effective Weight-Loss Drug Yet?
The obesity treatment landscape continues to evolve rapidly, and few investigational therapies have generated as much excitement as Retatrutide. Developed […]